Table 4. Comparison of the IHC subtypes obtained in the MIUCB and in the respective LNM using CK5 and CK20.
LNM IHC subtype CK5/CK20 n (%) | |||||
---|---|---|---|---|---|
basal | luminal | double negative | double positive | Total | |
MIUCB IHC subtype CK5/CK20 | |||||
basal | 16 (21.9) | 0 (0.0) | 2 (2.7) | 4 (5.5) | 22 (30.1) |
luminal | 0 (0.0) | 22 (30.1) | 2 (2.7) | 5 (6.8) | 29 (39.7) |
double negative | 0 (0.0) | 2 (2.7) | 5 (6.8) | 1 (1.4) | 8 (11.0) |
double positive | 1 (1.4) | 5 (6.8) | 0 (0.0) | 8 (11.0) | 14 (19.2) |
Total | 17 (23.3) | 29 (39.7) | 9 (12.3) | 18 (24.7) | 73 (100.0) |
McNemar-Bowker test: p value=0.440; Kappa coefficient=0.58.
Abbreviations: IHC, immunohistochemical; MIUCB, muscle-invasive urothelial carcinomas of the bladder; LNM, lymph node metastasis.